Press release
Metabolic Dysfunction-Associated Steatohepatitis Drugs Market to Grow at 18.1% CAGR, Reaching USD 929.05 million by 2033 | DataM Intelligence
Metabolic Dysfunction-Associated Steatohepatitis Drugs Market
United States: Recent Industry Developments
✅ In October 2025, Madrigal Pharmaceuticals received FDA accelerated approval for resmetirom, the first targeted therapy for MASH with liver fibrosis.
✅ In October 2025, Novo Nordisk initiated a Phase III clinical trial combining semaglutide with a novel FXR agonist for synergistic MASH treatment.
✅ In October 2025, the NIH allocated USD 150 million for research on non-invasive MASH diagnostics and novel therapeutic targets.
Japan: Recent Industry Developments
✅ In October 2025, Takeda Pharmaceutical entered a strategic collaboration to develop a novel PPAR agonist for MASH treatment in Asian populations.
✅ In October 2025, the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) established expedited review pathways for MASH therapies.
✅ In October 2025, Mitsubishi Tanabe Pharma launched a large-scale biomarker discovery program for MASH progression and treatment response.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/metabolic-dysfunction-associated-steatohepatitis-mash-drugs-market?jd
Market Trends & Drivers
The MASH Drugs Market is experiencing rapid growth driven by the increasing global prevalence of metabolic syndrome, rising obesity rates, and growing awareness of liver disease progression. Key trends include the development of combination therapies, advancement of non-invasive diagnostics, and targeted approaches addressing specific metabolic pathways. The significant unmet medical need, improving regulatory pathways, and expanding treatment guidelines are significantly accelerating market development.
Competitive Landscape
The market features intense competition among pharmaceutical companies, biotechnology firms, and research institutions.
Madrigal Pharmaceuticals, Inc. leads with resmetirom, the first FDA-approved therapy for MASH with liver fibrosis.
Intercept Pharmaceuticals, Inc. pioneers FXR agonist development with obeticholic acid for MASH treatment.
Novo Nordisk A/S leverages GLP-1 receptor agonist expertise for metabolic dysfunction management in MASH.
Pfizer Inc. advances multiple pipeline candidates targeting inflammatory and fibrotic pathways in MASH.
Bristol-Myers Squibb Company develops novel combinations addressing metabolic, inflammatory, and fibrotic components.
Takeda Pharmaceutical Company Limited focuses on Asian-specific MASH therapies and combination approaches.
Galmed Pharmaceuticals Ltd. specializes in liver-targeted therapies for metabolic liver diseases.
Viking Therapeutics, Inc. develops selective thyroid hormone receptor beta agonists for MASH treatment.
89bio, Inc. advances FGF21 analog therapy for metabolic dysfunction-associated conditions.
Sagimet Biosciences Inc. focuses on FASN inhibitors for de novo lipogenesis reduction in MASH.
Segmentation
By Disease Stage [Intraoral X-ray, Extraoral X-ray, Imaging Software, Others]
By Medication [2D Digital Radiography, 3D CBCT, Optical/Impression Scanners, Digital Sensors, Hybrid Systems]
By Route of Administration [Endodontics, Implantology, Orthodontics, Oral & Maxillofacial Surgery, Others]
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/metabolic-dysfunction-associated-steatohepatitis-mash-drugs-market?jd
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, Rest of Europe)
⇥ Asia-Pacific (Japan, China, India, South Korea, Australia, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd
✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends
Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us:
At DataM Intelligence, we provide more than just data-we deliver end-to-end business solutions. From deep-dive research to strategic consulting, we partner with you to turn complex market trends into a clear competitive advantage.
Leveraging our extensive database of 6,300+ reports across 40+ domains, we offer the insights and astute recommendations you need to make confident decisions. We are proud to support 200+ companies worldwide in navigating their key business challenges and accelerating their growth trajectory.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Metabolic Dysfunction-Associated Steatohepatitis Drugs Market to Grow at 18.1% CAGR, Reaching USD 929.05 million by 2033 | DataM Intelligence here
News-ID: 4245115 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Global Neobanking Market Surges at 49.2% CAGR Through 2031, Dominated by Europe' …
The Global Neobanking Market will grow at a high CAGR of 49.2% during the forecast period 2024- 2031.
Market growth is driven by the rapid adoption of digital-only banking channels, surging smartphone and internet penetration, and rising demand for low-cost, convenient financial services among retail and SME customers. Increasing fintech-bank partnerships, supportive regulatory sandboxes, accelerated cashless payment trends, and continuous innovation in embedded finance and Banking-as-a-Service (BaaS) offerings are further propelling…
United States Flip Chip Technology Market to Reach at CAGR 9.0% | North America …
The Flip Chip Technology Market is projected to expand at a compound annual growth rate (CAGR) of 9.0% between 2024 and 2031.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/flip-chip-technology-market?kb
United States: Recent Industry Developments
✅ January 2026: Amkor Technology unveiled advanced flip chip packaging solutions to support high-performance computing and 5G infrastructure.
✅ December 2025: Intel invested in domestic flip chip assembly plants to strengthen…
Viral Inactivation Market to Reach US$ 3.18 Billion by 2032 at 12.4% CAGR; North …
The Viral Inactivation Market reached US$ 1.98 billion in 2024 and is expected to reach US$ 3.18 billion by 2032, growing at a CAGR of 12.4% during the forecast period 2025-2032. The market is expanding steadily as viral inactivation has become a critical step in ensuring the safety of biologics, vaccines, blood products, and plasma-derived therapies.
Growth is driven by rising production of biologics and biosimilars, increasing demand for blood safety,…
Live Cell Imaging Market to Reach US$ 6.8 Billion by 2032 at 11.2% CAGR; North A …
The Live Cell Imaging Market reached US$ 2.9 billion in 2024 and is expected to reach US$ 6.8 billion by 2032, growing at a CAGR of 11.2% during the forecast period 2025-2032. The market is expanding steadily as live cell imaging becomes a critical technique for observing cellular dynamics, structure, and behavior in real time across life sciences and biomedical research.
Growth is driven by increasing adoption in drug discovery, cancer…
More Releases for MASH
Key Trends Reshaping the Metabolic Dysfunction-Associated Steatohepatitis (MASH) …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment Market Size Growth Forecast: What to Expect by 2025?
The market size pertaining to treatments for metabolic dysfunction-associated steatohepatitis (MASH) has witnessed substantial expansion lately, projected to surge from its 2024 valuation of $2 billion euros to $2.59 billion euros by 2025, reflecting a…
MASH Market Momentum: Late-Stage Assets Fuel Competitive Therapeutic Landscape
Metabolic Dysfunction-Associated Steatohepatitis (MASH), formerly known as Nonalcoholic Steatohepatitis (NASH), is becoming an increasingly urgent global public health issue. This progressive liver disease, characterized by fat buildup in the liver unrelated to alcohol consumption, can lead to inflammation (hepatitis), fibrosis, cirrhosis, and eventually liver cancer.
Download Strategic Sample PDF: https://datamintelligence.com/strategic-insights/sample/metabolic-dysfunction-associated-steatohepatitis-mash?ophp
Akero Therapeutics Completes Enrollment for Double-Blind Phase III SYNCHRONY Real-World Study of Efruxifermin (EFX) in Patients with Non-Invasively Diagnosed MASH or MASLD…
Fermented Pepper Mash Market Revenue, Insights, Overview, Outlook, Analysis | Va …
Fermented Pepper Mash Market
Fermented Pepper Mash is one of the most commonly used ingredients in kitchens and hot sauce manufacturers. This product is ideal for making medium-heat hot sauces and marinades. One can add small amounts to stews, soups and pastes to give them a mild flavor. Additionally, people can create their own homemade sauce by adding garlic, onions, vinegar, sugar, lemon juice, and more ingredients.
According to new survey, global…
Pepper Mash Market Production, Consumption, Export-Import Analysis Through 2030
** Market Overview **
Pepper mash refers to a mixture of ground black peppercorns in brine, vinegar or other solutions that is used to impart flavor, spice and heat to various food products. It is used in sauces, marinades, snacks, meat products and other culinary applications across the world.
The growth of the global pepper mash market is being driven by rising demand for convenience foods, growing adoption of international cuisines and…
Mash Tun Media: New UK Marketing Agency working exclusively with breweries
Mash Tun Media, the latest and most focused Digital Marketing Agency for Microbreweries has been developed and launched by the team at Future State Media.
Developing niche-specific skills and understanding of the unique demands of the microbrewing market has been a passion of the team at Future State Media for the past year. Working in the brewing niche has aligned so well with existing successful projects where the team had…
TV Antennas Market Size Mash up 2020-2025 - Worldwide Growth and Services Overvi …
(United States, OR Poland) : A complete research offering of a comprehensive analysis of the market share, size, recent developments, and trends can be availed in this latest report by Big Market Research. As per the report, the Global TV Antennas Market is anticipated to witness significant growth during the forecast period from 2020 to 2025.
The report provides brief summary and detailed insights into the market by collecting data…
